Advances on EGFR mutation for lung cancer

Por Metro, Giulio, Crinò, Lucio
Publicado no Transl Lung Cancer Res (2012)

Years of sorafenib investigation in advanced non-small cell lung cancer: is there a ‘NExUS’ linking an unsuccessful treatment and a potentially active one?

Por Metro, Giulio, Minotti, Vincenzo, Crinò, Lucio
Publicado em 2012

Non-coding RNAs in lung cancer

Por Ricciuti, Biagio, Mecca, Carmen, Crinò, Lucio, Baglivo, Sara, Cenci, Matteo, Metro, Giulio
Publicado no Oncoscience (2014)

Conditional robustness analysis for fragility discovery and target identification in biochemical networks and in cancer systems biology

Por Bianconi, Fortunato, Baldelli, Elisa, Luovini, Vienna, Petricoin, Emanuel F., Crinò, Lucio, Valigi, Paolo
Publicado no BMC Syst Biol (2015)

Erratum to: ‘Conditional robustness analysis for fragility discovery and target identification in biochemical networks and in cancer systems biology’

Por Bianconi, Fortunato, Baldelli, Elisa, Ludovini, Vienna, Petricoin, Emanuel F., Crinò, Lucio, Valigi, Paolo
Publicado no BMC Syst Biol (2016)

Dyskerin and TERC expression may condition survival in lung cancer patients

Por Penzo, Marianna, Ludovini, Vienna, Treré, Davide, Siggillino, Annamaria, Vannucci, Jacopo, Bellezza, Guido, Crinò, Lucio, Montanaro, Lorenzo
Publicado no Oncotarget (2015)

CYP17, GSTP1, PON1 and GLO1 gene polymorphisms as risk factors for breast cancer: an Italian case-control study

Por Antognelli, Cinzia, Del Buono, Chiara, Ludovini, Vienna, Gori, Stefania, Talesa, Vincenzo N, Crinò, Lucio, Barberini, Francesco, Rulli, Antonio
Publicado em 2009

Optimizing the Detection of Lung Cancer Patients Harboring Anaplastic Lymphoma Kinase (ALK) Gene Rearrangements Potentially Suitable for ALK Inhibitor Treatment

Por Camidge, D. Ross, Kono, Scott A., Flacco, Antonella, Tan, Aik-Choon, Doebele, Robert C., Zhou, Qing, Crino, Lucio, Franklin, Wilbur A., Varella-Garcia, Marileila
Publicado em 2010

Enteric-type adenocarcinoma of the lung harbouring a novel KRAS Q22K mutation with concomitant KRAS polysomy: a case report

Por Metro, Giulio, Valtorta, Emanuele, Siggillino, Annamaria, Lauricella, Calogero, Cenci, Matteo, Ludovini, Vienna, Minenza, Elisa, Prosperi, Enrico, Ricciuti, Biagio, Rebonato, Alberto, Bassetti, Alessandra, Crinò, Lucio
Publicado no Ecancermedicalscience (2015)

Ductal Breast Carcinoma Metastatic to the Stomach Resembling Primary Linitis Plastica in a Male Patient

Por Ricciuti, Biagio, Leonardi, Giulia Costanza, Ravaioli, Noemi, De Giglio, Andrea, Brambilla, Marta, Prosperi, Enrico, Ribacchi, Franca, Meacci, Marialuisa, Crinò, Lucio, Maiettini, Daniele, Chiari, Rita, Metro, Giulio
Publicado no J Breast Cancer (2016)

Gene identification for risk of relapse in stage I lung adenocarcinoma patients: a combined methodology of gene expression profiling and computational gene network analysis

Por Ludovini, Vienna, Bianconi, Fortunato, Siggillino, Annamaria, Piobbico, Danilo, Vannucci, Jacopo, Metro, Giulio, Chiari, Rita, Bellezza, Guido, Puma, Francesco, Fazia, Maria Agnese Della, Servillo, Giuseppe, Crinò, Lucio
Publicado no Oncotarget (2016)

hMENA splicing program impacts the clinical outcome of early stage lung cancer patients. How and why?

Por Visca, Paolo, Spada, Sheila, Di Modugno, Francesca, Bria, Emilio, Sperduti, Isabella, Antoniani, Barbara, Alessandrini, Gabriele, Palermo, Belinda, Ludovini, Vienna, Crinò, Lucio, Facciolo, Francesco, Milella, Michele, Mottolese, Marcella, Nisticò, Paola
Publicado em 2014

MYC and Human Telomerase Gene (TERC) Copy Number Gain in Early-stage Non–small Cell Lung Cancer

Por Flacco, Antonella, Ludovini, Vienna, Bianconi, Fortunato, Ragusa, Mark, Bellezza, Guido, Tofanetti, Francesca R., Pistola, Lorenza, Siggillino, Annamaria, Vannucci, Jacopo, Cagini, Lucio, Sidoni, Angelo, Puma, Francesco, Varella-Garcia, Marileila, Crinò, Lucio
Publicado no Am J Clin Oncol (2015)

Assessment of EGFR Mutations in Circulating Tumor Cell Preparations from NSCLC Patients by Next Generation Sequencing: Toward a Real-Time Liquid Biopsy for Treatment

Por Marchetti, Antonio, Del Grammastro, Maela, Felicioni, Lara, Malatesta, Sara, Filice, Giampaolo, Centi, Irene, De Pas, Tommaso, Santoro, Armando, Chella, Antonio, Brandes, Alba Ariela, Venturino, Paola, Cuccurullo, Franco, Crinò, Lucio, Buttitta, Fiamma
Publicado em 2014

miRNAs and resistance to EGFR—TKIs in EGFR-mutant non-small cell lung cancer: beyond ‘traditional mechanisms’ of resistance

Por Ricciuti, Biagio, Mecca, Carmen, Cenci, Matteo, Leonardi, Giulia Costanza, Perrone, Lorenzo, Mencaroni, Clelia, Crinò, Lucio, Grignani, Francesco, Baglivo, Sara, Chiari, Rita, Sidoni, Angelo, Paglialunga, Luca, Currà, Maria Francesca, Murano, Emanuele, Minotti, Vincenzo, Metro, Giulio
Publicado no Ecancermedicalscience (2015)

Gene Mutation Analysis in EGFR Wild Type NSCLC Responsive to Erlotinib: Are There Features to Guide Patient Selection?

Por Ulivi, Paola, Delmonte, Angelo, Chiadini, Elisa, Calistri, Daniele, Papi, Maximilian, Mariotti, Marita, Verlicchi, Alberto, Ragazzini, Angela, Capelli, Laura, Gamboni, Alessandro, Puccetti, Maurizio, Dubini, Alessandra, Burgio, Marco Angelo, Casanova, Claudia, Crinò, Lucio, Amadori, Dino, Dazzi, Claudio
Publicado no Int J Mol Sci (2014)

Functional signaling pathway analysis of lung adenocarcinomas identifies novel therapeutic targets for KRAS mutant tumors

Por Baldelli, Elisa, Bellezza, Guido, Haura, Eric B., Crinó, Lucio, Cress, W. Douglas, Deng, Jianghong, Ludovini, Vienna, Sidoni, Angelo, Schabath, Matthew B., Puma, Francesco, Vannucci, Jacopo, Siggillino, Annamaria, Liotta, Lance A., Petricoin, Emanuel F., Pierobon, Mariaelena
Publicado no Oncotarget (2015)

Randomized Phase II Study of Erlotinib in Combination With Placebo or R1507, a Monoclonal Antibody to Insulin-Like Growth Factor-1 Receptor, for Advanced-Stage Non–Small-Cell Lung...

Por Ramalingam, Suresh S., Spigel, David R., Chen, David, Steins, Martin B., Engelman, Jeffrey A., Schneider, Claus-Peter, Novello, Silvia, Eberhardt, Wilfried E.E., Crino, Lucio, Habben, Kai, Liu, Lian, Jänne, Pasi A., Brownstein, Carrie M., Reck, Martin
Publicado no J Clin Oncol (2011)

Clinical Experience With Crizotinib in Patients With Advanced ALK-Rearranged Non–Small-Cell Lung Cancer and Brain Metastases

Por Costa, Daniel B., Shaw, Alice T., Ou, Sai-Hong I., Solomon, Benjamin J., Riely, Gregory J., Ahn, Myung-Ju, Zhou, Caicun, Shreeve, S. Martin, Selaru, Paulina, Polli, Anna, Schnell, Patrick, Wilner, Keith D., Wiltshire, Robin, Camidge, D. Ross, Crinò, Lucio
Publicado no J Clin Oncol (2015)

Prognostic impact of alternative splicing-derived hMENA isoforms in resected, node-negative, non-small-cell lung cancer

Por Bria, Emilio, Modugno, Francesca Di, Sperduti, Isabella, Iapicca, Pierluigi, Visca, Paolo, Alessandrini, Gabriele, Antoniani, Barbara, Pilotto, Sara, Ludovini, Vienna, Vannucci, Jacopo, Bellezza, Guido, Sidoni, Angelo, Tortora, Giampaolo, Radisky, Derek C., Crinò, Lucio, Cognetti, Francesco, Facciolo, Francesco, Mottolese, Marcella, Milella, Michele, Nisticò, Paola
Publicado no Oncotarget (2014)